Key statistics
On Tuesday, Elevation Oncology Inc (ELEV:NSQ) closed at 0.5224, 43.91% above the 52 week low of 0.363 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.5462 |
---|---|
High | 0.56 |
Low | 0.5224 |
Bid | 0.5213 |
Offer | 0.5444 |
Previous close | 0.5424 |
Average volume | 791.02k |
---|---|
Shares outstanding | 59.11m |
Free float | 56.93m |
P/E (TTM) | -- |
Market cap | 32.06m USD |
EPS (TTM) | -0.8399 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Press releases
- Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2
- Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Elevation Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business Achievements
- Elevation Oncology Announces Promising Initial Data from Phase 1 Clinical Trial Evaluating EO-3021 in Patients with Advanced Unresectable or Metastatic Solid Tumors Likely to Express Claudin 18.2